SEARLE & CO. - XERIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SEARLE & CO. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$49,000
-49.5%
20,000
-7.0%
0.02%
-53.5%
Q1 2021$97,000
-41.9%
21,500
-36.8%
0.04%
-46.2%
Q4 2020$167,000
+12.8%
34,000
-50.7%
0.08%
-7.0%
Q2 2020$148,000
+46.5%
69,000
+32.7%
0.09%
+19.4%
Q1 2020$101,00052,0000.07%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders